BCDA · BioCardia, Inc.
$0.85
-0.06 (-6.26%)
At close · Jul 24
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about our ability to continue as a going concern beyond one year from the date these financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed May 15, 2026
Market Cap
$9.67M
Shares
11.37M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.91
Open$0.91
Day$0.85–0.92
52W$0.78–2.42
Avg vol 30d900K
Short int1.3M · 11.8% float · 2.6d
Short vol54%
Last earningsMay 15, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 15
Up next
Next earnings call
Aug 14, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−24%
below
Price vs 50-day avg
−6%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
8%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−14%
trailing
6-month return
−28%
trailing
YTD return
−27%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
3 of 18 funds reported for Jun 30 · net +19.9K sh shares · +2 new
Insider flow
Accumulating
Net +$144.0K over 90 days · 0% sells
Short interest
Rising
11.81% of float · ▲ +261.2% MoM · 2.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
18 holders — mid 2-yr range
Squeeze score
73
high risk · 0–100
Fundamentals
Revenue growth
−17%
Y/Y
Gross margin
13%
expanding
Free cash flow
$-7.4M
Balance sheet
$2.5M
net cash
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
10.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−24%
Bearish
Price vs 50-day avg
−6%
Bearish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
8%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
3 of 18 funds reported for Jun 30 · net +19.9K sh shares · +2 new
Insider flow
Accumulating
Net +$144.0K over 90 days · 0% sells
Short interest
Rising
11.81% of float · ▲ +261.2% MoM · 2.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
18 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 8%
52-wk high $2
vs 200-day avg -24%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BCDA
this stock
BioCardia, Inc.
|
$9.67M | -27.2% | -16.8% | — | 11.8% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BCDA | +5.8% | -14.2% | -27.8% | -26.6% | -27.2% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +7.5% | -14.8% | -34.1% | -25.5% | -35.5% |